CoChat

Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy

Zhang, Fan, Liu, Yani, Tang, Feng, Liang, Bo, Chen, Huanming, Zhang, Hailin, Wang, Kewei · 2019 · The FASEB Journal
Cited by 35

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Voltage‐gated Kv7/KCNQ/M potassium channels play an essential role in the control of membrane potential and neuronal excitability. Activation of the neuronal Kv7/KCNQ/M‐current represents an attractive therapeutic strategy for treatment of hyperexcitability‐related neuropsychiatric disorders such as epilepsy, pain, and depression, which is an unmet medical need. In this study, we synthesized and characterized a novel compound, N ‐(4‐(2‐bromo‐6,7‐dihydrothieno[3,2‐ c ]pyridin‐5(4 H )‐yl)‐2,6‐dimethylphenyl)‐3,3‐dimethylbutanamide (SCR2682) 2,6‐dimethyl‐4‐(piperidin‐yl) phenyl)‐amide derivative, that exhibits selective and potent activation of neuronal Kv7/KCNQ/M‐channels. Whole‐cell patch‐clamp recordings of human embryonic kidney 293 cells expressing Kv7.2/Kv7.3 channels show that SCR2682 selectively activates the channel current in a dose‐dependent manner with an EC 50 of 9.8 ± 0.4 nM, which is ∼100‐fold more potent than a U.S. Food and Drug Administration–approved antiepileptic drug (retigabine) for treatment of partial epilepsy. SCR2682 shifts voltage‐dependent activation of the Kv7.2/7.3 current toward more negative membrane potential, to about −37 mV ( V 1/2 ). SCR2682 also activates the native M‐current in rat hippocampal or cortical neurons, causing marked hyperpolarization and potent inhibition of neuronal firings. Mechanistically, mutating the tryptophan residue 236 located at the fifth transmembrane segment of Kv7.2 abolishes the chemical activation of the channel by SCR2682. Furthermore, intraperitoneal or intragastric administration of SCR2682 results in a dose‐dependent inhibition of seizures by maximal electroshock. Taken together, our findings demonstrate that a novel small molecule, SCR2682, selectively and potently activates neuronal Kv7 channels and reverses epileptic seizures in rodents. Thus, SCR2682 may warrant further evaluation for clinical development of antiepileptic therapy.—Zhang, F., Liu, Y., Tang, F., Liang, B., Chen, H., Zhang, H., Wang, K. Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy. FASEB J. 33, 9154–9166 (2019). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.201802848rr

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 35

Metadata

Authors
Zhang, F., Liu, Y., Tang, F., Liang, B., Chen, H., Zhang, H., & Wang, K.
Venue
The FASEB Journal
Publisher
Wiley
Published
2019-05-07
Volume
33
Issue
8
Pages
9154-9166
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2944262283
Cited by
35
References
3
FWCI
1.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy. https://app.cochat.ai/papers/10.1096/fj.201802848rr
The paper
Zhang, F., Liu, Y., Tang, F., Liang, B., Chen, H., Zhang, H., & Wang, K. (2019). Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy. The FASEB Journal. https://doi.org/10.1096/fj.201802848rr

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.